glp-1 and sarcopenia Muscle loss GLP-1R agonists use | Acta Diabetologica Sarcopenia‐related changes in serum GLP‐1
Description
How people are using GLP-1s People with type 2 diabetes are using GLP-1 receptor agonists to improve glycemic control, reduce reliance on insulin/other drugs, and reduce risk of diabetes-related complications

Patients who started tirzepatide but discontinued before reaching 10 mg lost 8.1% of baseline weight

Seaweed or kelp supplements should be avoided due to variable and potentially excessive iodine content

In October 2023, the FDA cleared the use of Bimzelx for adult patients with moderate-to-severe plaque psoriasis and in September 2024 expanded its label to include psoriatic arthritis, ankylosing sspondylitis and non-radiographic axial spondyloarthritis

He believes GLP-1 agonists should be tried sooner rather than later
